ID: ALA4560583

Max Phase: Preclinical

Molecular Formula: C9H5N3O2

Molecular Weight: 187.16

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  N#Cc1c(O)c2ccncc2[nH]c1=O

Standard InChI:  InChI=1S/C9H5N3O2/c10-3-6-8(13)5-1-2-11-4-7(5)12-9(6)14/h1-2,4H,(H2,12,13,14)

Standard InChI Key:  NPAMRWDIMURYSE-UHFFFAOYSA-N

Associated Targets(Human)

KDM2B Tchem Lysine-specific demethylase 2B (347 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM4C Tchem Lysine-specific demethylase 4C (1129 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM5C Tchem Lysine-specific demethylase 5C (224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM5B Tchem Lysine-specific demethylase 5B (814 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM5A Tchem Lysine-specific demethylase 5A (893 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 187.16Molecular Weight (Monoisotopic): 187.0382AlogP: 0.50#Rotatable Bonds: 0
Polar Surface Area: 89.77Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 5.16CX Basic pKa: 3.39CX LogP: -0.73CX LogD: -2.75
Aromatic Rings: 2Heavy Atoms: 14QED Weighted: 0.63Np Likeness Score: -0.75

References

1. Labadie SS, Dragovich PS, Cummings RT, Deshmukh G, Gustafson A, Han N, Harmange JC, Kiefer JR, Li Y, Liang J, Liederer BM, Liu Y, Manieri W, Mao W, Murray L, Ortwine DF, Trojer P, VanderPorten E, Vinogradova M, Wen L..  (2016)  Design and evaluation of 1,7-naphthyridones as novel KDM5 inhibitors.,  26  (18): [PMID:27499454] [10.1016/j.bmcl.2016.07.070]

Source